MedTrace Logo

Endometrial Preparation by Short Course of Letrozole Before Hysteroscopic Removal of Endocavitary Lesions

NCT04364581 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2020-04-28

No results posted yet for this study

Summary

The aim of this study is to evaluate the effectiveness of short course of letrozole for endometrial preparation before hysteroscopic surgery for intracavitary lesions.

Conditions

  • Myoma;Uterus

Interventions

DRUG

Letrozole

Women will be treated with letrozole (5 mg daily) for 10 days before hysteroscopic intervention

DRUG

Placebo

Women will be treated with placebo for 10 days before hysteroscopic intervention

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • Yomna Ayman · Mansoura University

  • Mohamed S Abdelhafez, MD · Mansoura University

  • Rafik I Barakat, MD · Mansoura University

  • Tarek A Shokir, MD · Mansoura University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2021-05-01
Completion
2021-05-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04364581 on ClinicalTrials.gov